Estimates Revisions Filana Therapeutics, Inc.
Stocks
FLNA
US14817C1071
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.8573 USD | -4.53% |
|
-7.82% | -56.70% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- FLNA Stock
- Consensus Filana Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
